The oligoadenylate-RNAseL pathway may provide a specific and low toxicity approach to therapy for breast cancer

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1047149

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

We have discovered that a pathway used to fight viral infections can be triggered to produce massive cell death in the mammary gland. We hope to be able to trigger this response in breast cancers through the strategic combination of available drugs. If successful this project will establish a new therapeutic strategy for breast cancer.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2015

Funding Scheme: Project Grants

Funding Amount: $439,314.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Molecular Targets

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

breast cancer | breast function | cancer cell biology | cancer chemotherapy | innate immunity

Related Links